Skip to content
Menu
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Astellas Pharma Inc. ALPMY

Full chart Compare
Set alert

Price alert · ALPMY

All alert types
16.85 USD +0.34 (+2.06%)

Regular-session close

16.75 Day range 17.38
11.97 52-week range 16.85
YTD
+26.79%
1 year
+40.77%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Sign in

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Sign in

Financial health

Altman Z-Score

3.63 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A+4 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 3
  • P/B 3

Valuation

P/E 14.9×
FY 2017: 14.2×FY 2018: 20.0×FY 2019: 14.8×FY 2020: 15.7×FY 2021: 26.3×FY 2022: 28.3×FY 2023: 34.7×FY 2024: 172×FY 2025: 51.1×FY 2026: 14.9×
FY 2017 5y median 34.7× FY 2026
P/S 2.0×
FY 2017: 2.4×FY 2018: 2.5×FY 2019: 2.5×FY 2020: 2.4×FY 2021: 2.5×FY 2022: 2.7×FY 2023: 2.3×FY 2024: 1.8×FY 2025: 1.4×FY 2026: 2.0×
FY 2017 5y median 2.0× FY 2026
P/B 2.5×
FY 2017: 2.4×FY 2018: 2.6×FY 2019: 2.6×FY 2020: 2.4×FY 2021: 2.3×FY 2022: 2.4×FY 2023: 2.3×FY 2024: 1.8×FY 2025: 1.7×FY 2026: 2.5×
FY 2017 5y median 2.3× FY 2026
P/FCF 8.6×
FY 2017: 16.4×FY 2018: 12.0×FY 2019: 15.7×FY 2020: 21.0×FY 2021: 13.8×FY 2022: 19.3×FY 2023: 14.1×FY 2024: 32.5×FY 2025: 19.0×FY 2026: 8.6×
FY 2017 5y median 19.0× FY 2026
EV/EBITDA 7.2×
FY 2017: 7.9×FY 2018: 10.4×FY 2019: 9.5×FY 2020: 10.0×FY 2021: 14.2×FY 2022: 14.1×FY 2023: 13.2×FY 2024: 18.0×FY 2025: 13.1×FY 2026: 7.2×
FY 2017 5y median 13.2× FY 2026
EV/Sales 2.0×
FY 2017: 2.1×FY 2018: 2.3×FY 2019: 2.3×FY 2020: 2.4×FY 2021: 2.5×FY 2022: 2.6×FY 2023: 2.1×FY 2024: 2.2×FY 2025: 1.7×FY 2026: 2.0×
FY 2017 5y median 2.1× FY 2026
FCF Yield 11.7%
FY 2017: 6.1%FY 2018: 8.3%FY 2019: 6.4%FY 2020: 4.8%FY 2021: 7.3%FY 2022: 5.2%FY 2023: 7.1%FY 2024: 3.1%FY 2025: 5.3%FY 2026: 11.7%
FY 2017 5y median 5.3% FY 2026

Profitability

Gross Margin 74.6%
FY 2017: 72.8%FY 2018: 74.6%FY 2019: 74.9%FY 2020: 77.1%FY 2021: 78.4%FY 2022: 78.3%FY 2023: 78.5%FY 2024: 81.8%FY 2025: 81.7%FY 2026: 74.6%
FY 2017 5y median 78.5% FY 2026
Operating Margin 19.6%
FY 2017: 21.1%FY 2018: 20.9%FY 2019: 21.4%FY 2020: 21.5%FY 2021: 10.9%FY 2022: 12.0%FY 2023: 18.8%FY 2024: 1.6%FY 2025: 2.1%FY 2026: 19.6%
FY 2017 5y median 12.0% FY 2026
Net Margin 13.6%
FY 2017: 16.7%FY 2018: 12.7%FY 2019: 17.0%FY 2020: 15.0%FY 2021: 9.7%FY 2022: 9.6%FY 2023: 6.5%FY 2024: 1.1%FY 2025: 2.7%FY 2026: 13.6%
FY 2017 5y median 6.5% FY 2026
ROE 16.8%
FY 2017: 17.2%FY 2018: 13.0%FY 2019: 17.7%FY 2020: 15.2%FY 2021: 8.7%FY 2022: 8.5%FY 2023: 6.5%FY 2024: 1.1%FY 2025: 3.4%FY 2026: 16.8%
FY 2017 5y median 6.5% FY 2026
ROIC 13.2%
FY 2017: 15.2%FY 2018: 14.3%FY 2019: 17.9%FY 2020: 12.1%FY 2021: 6.2%FY 2022: 6.8%FY 2023: 11.7%FY 2024: 0.6%FY 2025: 1.6%FY 2026: 13.2%
FY 2017 5y median 6.8% FY 2026
ROA 8.6%
FY 2017: 12.1%FY 2018: 8.9%FY 2019: 11.7%FY 2020: 8.4%FY 2021: 5.3%FY 2022: 5.3%FY 2023: 4.0%FY 2024: 0.5%FY 2025: 1.5%FY 2026: 8.6%
FY 2017 5y median 4.0% FY 2026

Growth (YoY)

Revenue 18.6%
FY 2017: -4.4%FY 2018: -0.9%FY 2019: 0.5%FY 2020: -0.4%FY 2021: -3.9%FY 2022: 3.7%FY 2023: 17.2%FY 2024: 5.6%FY 2025: 19.2%FY 2026: 18.6%
FY 2017 FY 2026
Operating Income 984.4%
FY 2017: 2.2%FY 2018: -1.9%FY 2019: 3.3%FY 2020: -0.3%FY 2021: -51.3%FY 2022: 14.4%FY 2023: 83.3%FY 2024: -91.1%FY 2025: 60.8%FY 2026: 984.4%
FY 2017 FY 2026
EPS (diluted) 511.0%
FY 2017: 15.5%FY 2018: -21.8%FY 2019: 41.9%FY 2020: -9.4%FY 2021: -37.6%FY 2022: 3.3%FY 2023: -19.3%FY 2024: -82.5%FY 2025: 198.2%FY 2026: 511.0%
FY 2017 FY 2026
Free Cash Flow 293.1%
FY 2017: -5.0%FY 2018: 45.4%FY 2019: -23.7%FY 2020: -30.2%FY 2021: 57.6%FY 2022: -21.1%FY 2023: 34.2%FY 2024: -63.1%FY 2025: 52.5%FY 2026: 293.1%
FY 2017 FY 2026

Financial Health

Current Ratio 1.2×
FY 2017: 2.2×FY 2018: 2.0×FY 2019: 1.7×FY 2020: 1.1×FY 2021: 1.5×FY 2022: 1.3×FY 2023: 1.4×FY 2024: 0.9×FY 2025: 1.1×FY 2026: 1.2×
FY 2017 5y median 1.2× FY 2026
Quick Ratio 0.9×
FY 2017: 1.7×FY 2018: 1.7×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 1.2×FY 2022: 1.1×FY 2023: 1.2×FY 2024: 0.7×FY 2025: 0.9×FY 2026: 0.9×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 0.1×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -0.1×
FY 2017: -1.0×FY 2018: -1.2×FY 2019: -1.0×FY 2020: 0.3×FY 2021: -0.2×FY 2022: -0.4×FY 2023: -0.7×FY 2024: 3.0×FY 2025: 2.6×FY 2026: -0.1×
FY 2017 5y median -0.1× FY 2026
Interest Coverage 29.8×
FY 2017: 207×FY 2018: 207×FY 2019: 215×FY 2020: 93.0×FY 2021: 58.3×FY 2022: 31.5×FY 2023: 32.5×FY 2024: 2.1×FY 2025: 2.3×FY 2026: 29.8×
FY 2017 5y median 29.8× FY 2026

Dividends

Dividend Yield 3.1%
FY 2017: 2.3%FY 2018: 2.2%FY 2019: 2.2%FY 2020: 2.4%FY 2021: 2.4%FY 2022: 2.4%FY 2023: 2.9%FY 2024: 4.0%FY 2025: 5.0%FY 2026: 3.1%
FY 2017 5y median 3.1% FY 2026
Payout Ratio 46.7%
FY 2017: 32.1%FY 2018: 43.5%FY 2019: 32.4%FY 2020: 37.6%FY 2021: 63.2%FY 2022: 68.7%FY 2023: 101.7%FY 2024: 684.4%FY 2025: 254.2%FY 2026: 46.7%
FY 2017 5y median 101.7% FY 2026

Annual · latest fiscal year ends 2026-03-31